Literature DB >> 3815338

Sensitivity to melphalan as a function of transport activity and proliferative rate in BALB/c 3T3 fibroblasts.

R Blosmanis, J A Wright, G J Goldenberg.   

Abstract

Melphalan transport by exponentially dividing BALB/c 3T3 mouse fibroblasts was approximately 3-fold greater at the steady-state than that observed with resting cells at drug concentrations ranging from 1 to 100 microM. Both the rate of incorporation of [3H]thymidine and the percentage of S-phase cells estimated by a fluorescent cell sorter provided evidence of higher DNA synthetic activity in logarithmic phase cells. Transport of melphalan by BALB/c 3T3 fibroblasts was mediated by the two amino acid transport systems, the DL-beta-2-aminobicyclo(2,2,1)heptane-2-carboxylic acid-sensitive sodium-independent system preferring leucine as substrate and the sodium-dependent system preferring alanine, serine, and cysteine as substrates. At low drug concentrations (about 1 microM) the sodium-dependent mechanism predominated, but at high concentrations of melphalan (100 microM) a shift occurred from the sodium-dependent to the sodium-independent system. Both transport systems were markedly affected by the proliferative state of the cells and became progressively less active the longer cells remained in the stationary phase. Stationary-phase cells were also less sensitive to the cytotoxic action of melphalan than exponentially dividing cells. Serum deprivation experiments showed that unidirectional melphalan influx decreased about 40% when fibroblasts previously in exponential growth were shifted from normal medium to serum-depleted medium 24 h prior to drug transport studies. Thus, serum deprivation and maintenance of cells in stationary phase growth had parallel effects on drug influx. These experiments emphasize the importance of the proliferative state of the cell as a determinant of melphalan transport and cytocidal activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3815338

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  A novel transforming growth factor-beta 1 responsive cytoplasmic trans-acting factor binds selectively to the 3'-untranslated region of mammalian ribonucleotide reductase R2 mRNA: role in message stability.

Authors:  F M Amara; F Y Chen; J A Wright
Journal:  Nucleic Acids Res       Date:  1993-10-11       Impact factor: 16.971

2.  Characterization of deoxyguanosine-resistant hypoxanthine-guanine phosphoribosyltransferase(-)metastatic variants altered in soybean-agglutinin-binding properties and cell-surface glycoproteins.

Authors:  J E Damen; M A Spearman; A H Greenberg; J A Wright
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential.

Authors:  H Fan; C Villegas; J A Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

4.  L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma.

Authors:  Jules Lin; Duna A Raoof; Dafydd G Thomas; Joel K Greenson; Thomas J Giordano; Gregory S Robinson; Maureen J Bourner; Christopher T Bauer; Mark B Orringer; David G Beer
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

5.  Regulation of mammalian ribonucleotide reductase R1 mRNA stability is mediated by a ribonucleotide reductase R1 mRNA 3'-untranslated region cis-trans interaction through a protein kinase C-controlled pathway.

Authors:  F Y Chen; F M Amara; J A Wright
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

6.  Defining a novel cis element in the 3'-untranslated region of mammalian ribonucleotide reductase component R2 mRNA: role in transforming growth factor-beta 1 induced mRNA stabilization.

Authors:  F M Amara; F Y Chen; J A Wright
Journal:  Nucleic Acids Res       Date:  1995-05-11       Impact factor: 16.971

7.  Mammalian ribonucleotide reductase R1 mRNA stability under normal and phorbol ester stimulating conditions: involvement of a cis-trans interaction at the 3' untranslated region.

Authors:  F Y Chen; F M Amara; J A Wright
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598

8.  Melphalan sensitivity as a function of progressive metastatic growth in two subpopulations of a mouse mammary tumour.

Authors:  B E Miller; F R Miller; T Machemer; G H Heppner
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

9.  Cytokinetic factors in drug resistance of Lewis lung carcinoma: comparison of cells freshly isolated from tumours with cells from exponential and plateau-phase cultures.

Authors:  G J Finlay; W R Wilson; B C Baguley
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

10.  Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma.

Authors:  Atsushi Isoda; Kyoichi Kaira; Masanori Iwashina; Noboru Oriuchi; Hideyuki Tominaga; Shushi Nagamori; Yoshikatsu Kanai; Tetsunari Oyama; Takayuki Asao; Morio Matsumoto; Morio Sawamura
Journal:  Cancer Sci       Date:  2014-10-09       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.